Nine percent of the transformed cases in the North American cohort also displayed EGFR-amplification, in addition to the founder EGFR-mutation [195], implicating that not only EGFR-downregulation but also -upregulation may contribute to the loss of sensitivity to EGFR-TKIs in the SCLC-transformed cells. Here, EGFR is linked to small cell lung carcinoma.